tiprankstipranks
Curis Inc (CRIS)
NASDAQ:CRIS
US Market

Curis (CRIS) Stock Forecast & Price Target

Compare
1,451 Followers
See the Price Targets and Ratings of:

CRIS Financial Forecast

CRIS Earnings Forecast

Currently, no earnings data available.
Currently, no earnings data available.

CRIS Sales Forecast

Currently, no sales data available.
Currently, no sales data available.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright
$20
Buy
736.82%
Upside
Reiterated
12/10/24
Promising Clinical Trial Results and Robust Financial Projections Drive Buy Rating for Emavusertib
Laidlaw
$20
Buy
736.82%
Upside
Reiterated
09/27/24
Laidlaw reiterates Buy Rating on Curis (CRIS)Laidlaw analyst Yale Jen reiterated a Buy rating and $20.00 price target on Curis (NASDAQ: CRIS).
JonesTrading
$18
Buy
653.14%
Upside
Reiterated
09/27/24
Analysts Offer Insights on Healthcare Companies: Curis (NASDAQ: CRIS), Scholar Rock Holding (NASDAQ: SRRK) and Travere Therapeutics (NASDAQ: TVTX)
Truist Financial
Buy
Reiterated
08/22/24
Truist Financial Sticks to Its Buy Rating for Curis (CRIS)
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright
$20
Buy
736.82%
Upside
Reiterated
12/10/24
Promising Clinical Trial Results and Robust Financial Projections Drive Buy Rating for Emavusertib
Laidlaw
$20
Buy
736.82%
Upside
Reiterated
09/27/24
Laidlaw reiterates Buy Rating on Curis (CRIS)Laidlaw analyst Yale Jen reiterated a Buy rating and $20.00 price target on Curis (NASDAQ: CRIS).
JonesTrading
$18
Buy
653.14%
Upside
Reiterated
09/27/24
Analysts Offer Insights on Healthcare Companies: Curis (NASDAQ: CRIS), Scholar Rock Holding (NASDAQ: SRRK) and Travere Therapeutics (NASDAQ: TVTX)
Truist Financial
Buy
Reiterated
08/22/24
Truist Financial Sticks to Its Buy Rating for Curis (CRIS)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

CRIS Analyst Recommendation Trends

Rating
Jun 24
Aug 24
Sep 24
Nov 24
Dec 24
Strong Buy
5
7
6
7
6
Buy
2
3
2
2
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
7
10
8
9
6
In the current month, CRIS has received 6 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. CRIS average Analyst price target in the past 3 months is $20.00.
Each month's total comprises the sum of three months' worth of ratings.

CRIS Stock Forecast FAQ

What is CRIS’s average 12-month price target, according to analysts?
Based on analyst ratings, Curis Inc’s 12-month average price target is $20.00.
    What is CRIS’s upside potential, based on the analysts’ average price target?
    Curis Inc has 736.82% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is CRIS a Buy, Sell or Hold?
          Curis Inc has a consensus rating of Moderate Buy which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Curis Inc’s price target?
            The average price target for Curis Inc is $20.00. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $20.00 ,the lowest forecast is $20.00. The average price target represents 736.82% Increase from the current price of $2.39.
              What do analysts say about Curis Inc?
              Curis Inc’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 0 Wall Streets Analysts.
                How can I buy shares of CRIS?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis